Veracyte Inc (VCYT)
42.65
-1.48
(-3.35%)
USD |
NASDAQ |
Dec 09, 14:24
Veracyte Price: 42.65 for Dec. 9, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 06, 2024 | 44.15 | 46.00 | 43.50 | 44.13 | 1.077M |
| Dec 05, 2024 | 42.00 | 43.39 | 42.00 | 42.84 | 763530.0 |
| Dec 04, 2024 | 43.50 | 44.50 | 43.01 | 44.09 | 643707.0 |
| Dec 03, 2024 | 43.37 | 43.77 | 42.64 | 43.66 | 629262.0 |
| Dec 02, 2024 | 43.00 | 44.45 | 42.72 | 44.12 | 1.165M |
| Nov 29, 2024 | 43.19 | 43.70 | 42.89 | 42.95 | 490418.0 |
| Nov 27, 2024 | 43.25 | 44.16 | 42.35 | 42.89 | 822169.0 |
| Nov 26, 2024 | 40.88 | 42.86 | 40.57 | 42.84 | 1.032M |
| Nov 25, 2024 | 40.00 | 41.32 | 39.99 | 41.10 | 716038.0 |
| Nov 22, 2024 | 38.79 | 39.75 | 38.13 | 39.59 | 714947.0 |
| Nov 21, 2024 | 39.38 | 39.81 | 38.73 | 38.94 | 634453.0 |
| Nov 20, 2024 | 39.16 | 39.80 | 38.61 | 39.20 | 632021.0 |
| Nov 19, 2024 | 36.40 | 39.19 | 36.38 | 39.15 | 850157.0 |
| Nov 18, 2024 | 36.05 | 37.30 | 35.73 | 36.71 | 804488.0 |
| Nov 15, 2024 | 37.76 | 37.76 | 35.37 | 35.94 | 1.627M |
| Nov 14, 2024 | 39.53 | 39.98 | 36.80 | 37.04 | 877283.0 |
| Nov 13, 2024 | 38.69 | 39.70 | 38.40 | 39.53 | 1.143M |
| Nov 12, 2024 | 38.52 | 38.78 | 37.92 | 38.24 | 873833.0 |
| Nov 11, 2024 | 36.94 | 38.93 | 36.94 | 38.89 | 1.050M |
| Nov 08, 2024 | 37.15 | 37.84 | 36.35 | 36.48 | 902733.0 |
| Nov 07, 2024 | 39.70 | 41.43 | 37.28 | 37.34 | 1.935M |
| Nov 06, 2024 | 36.77 | 37.40 | 35.89 | 36.59 | 1.198M |
| Nov 05, 2024 | 34.77 | 36.26 | 34.41 | 35.93 | 887982.0 |
| Nov 04, 2024 | 34.22 | 35.03 | 33.56 | 34.98 | 686664.0 |
| Nov 01, 2024 | 33.96 | 34.36 | 33.61 | 34.31 | 553888.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
15.31
Minimum
Oct 20 2022
81.38
Maximum
Feb 09 2021
30.90
Average
26.72
Median
Jun 02 2023
Price Benchmarks
| Fonar Corp | 15.70 |
| XWELL Inc | 1.43 |
| ProPhase Labs Inc | 0.724 |
| Applied DNA Sciences Inc | 0.20 |
| OncoCyte Corp | 2.52 |
Price Related Metrics
| PS Ratio | 7.608 |
| Price to Book Value | 2.811 |
| Price to Free Cash Flow | 57.29 |
| Earnings Yield | -0.35% |
| Market Cap | 3.305B |
| Operating PE Ratio | 294.27 |
| Normalized PE Ratio | 178.24 |